A Phase-III Trial Of Doxorubicin And Docetaxel Versus Doxorubicin And Paclitaxel In Metastatic Breast Cancer: Results Of The ERASME 3 Study
Philippe A. Cassier, Sylvie Chabaud, Véronique Trillet-Lenoir, Pierre-Yves Peaud, Jean-Dominique Tigaud, Hervé Cure, Hubert Orfeuvre, Bruno Salles, Claude Martin, Jean-Philippe Jacquin, Cecile Agostini, Jean-Paul Guastalla, David Pérol, Thomas Bachelot
Twitter
Facebook
LinkedIn
Email